Discovery of small molecule VEGFR-2 inhibitors with preferential ocular distribution and retention following oral dosing

被引：0

作者：

Meredith, Erik ^{[1
]}

Mainolfi, Nello ^{[1
]}

Poor, Stephen ^{[1
]}

Qiu, Yubin ^{[1
]}

Miranda, Karl ^{[1
]}

Powers, James ^{[1
]}

Liu, Donglei ^{[1
]}

Ma, Fupeng ^{[1
]}

Solovay, Catherine ^{[1
]}

Rao, Chang ^{[1
]}

Johnson, Leland ^{[1
]}

Ji, Nan ^{[1
]}

Artman, Gerald ^{[1
]}

Hardegger, Leo ^{[1
]}

Hanks, Shawn ^{[1
]}

Shen, Siyuan ^{[1
]}

Woolfenden, Amber ^{[1
]}

Fassbender, Elizabeth ^{[1
]}

Sivak, Jeremy ^{[1
]}

Zhang, Yiqin ^{[1
]}

Long, Debby ^{[1
]}

Cepeda, Rosemarie ^{[1
]}

Hosagrahara, Vinayak ^{[1
]}

Lee, Wendy ^{[1
]}

Tarsa, Peter ^{[1
]}

Liu, Fang ^{[1
]}

Anderson, Karen ^{[1
]}

Newton, Ronald ^{[1
]}

End, Peter ^{[1
]}

Elliott, Jason ^{[1
]}

Jaffee, Bruce ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Cambridge, MA USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

269

引用

页数：1

共 50 条

[21] Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase
Bhojwani, Heena R.
Joshi, Urmila J.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2017, 13 (03) : 186 - 207
[22] Design and discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and VEGFR-2
Zhang, Hai-Qi
Gong, Fei-Hu
Ye, Ji-Qing
Zhang, Chi
Yue, Xiao-Hong
Li, Chuan-Gui
Xu, Yun-Gen
Sun, Li-Ping
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 125 : 245 - 254
[23] In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy
Li, Jing
Zhou, Nan
Luo, Kun
Zhang, Wei
Li, Xinru
Wu, Chuanfang
Bao, Jinku
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09) : 15994 - 16011
[24] Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazo-line and diarylamide fragments
Wang, Ru
Liu, Hu
You, Yuan-Yuan
Wang, Xin-Yu
Lv, Bing-Bing
Cao, Li-Qin
Xue, Jia-Yu
Xu, Yun-Gen
Shi, Lei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 36
[25] Discovery of potential VEGFR-2 inhibitors from natural products by virtual screening and molecular dynamics simulation
Xie, Qiong
Luo, Mengshi
Liu, Mingyan
Xie, Yuxin
Li, Di
Dai, Hongjing
Chen, Xiaohua
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2025, 27 (07) : 3732 - 3747
[26] Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR
Zhang, Qingwen
Diao, Yuanyuan
Wang, Fei
Fu, Ying
Tang, Fei
You, Qidong
Zhou, Houyuan
MEDCHEMCOMM, 2013, 4 (06) : 979 - 986
[27] Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening
Usui, Taikou
Ban, Hyun Seung
Kawada, Junpei
Hirokawa, Takatsugu
Nakamura, Hiroyuki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 285 - 288
[28] Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors
Zhang, Hai-Qi
Gong, Fei-Hu
Li, Chuan-Gui
Zhang, Chi
Wang, Yan-Jie
Xu, Yun-Gen
Sun, Li-Ping
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 371 - 379
[29] Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies
Dhawale, Sachin A.
Dabhade, Pratap S.
Mokale, Santosh N.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (18) : 2042 - 2055
[30] 2-Cyanopyridines as novel VEGFR-2 / VEGFR-3 inhibitors. Part 1. Discovery and SAR of 2-Cyanopyridines
Scott, William J.
Adnane, Lila
Phillips, Barton
Chen, Yuanwei
Dixon, Julie A.
Dumas, Jacques
Lee, Wendy
Burke, Jennifer
Chandler, Brent
Chen, Jianqing
Chen, Zhi
Fan, Jianmei
Jones, Ben
Raudenbusch, Brian
Redman, Aniko
Shao, Jianxing
Yi, Lin
Zhu, Qingming
Cao, Yichen
Ichetovkin, Marina
Noell, Steve
Hofilena, Gloria
CANCER RESEARCH, 2006, 66 (08)

← 1 2 3 4 5 →